Catalyst MedTech Expands Partnership with Arineta
Catalyst MedTech, a leader in diagnostic imaging solutions, has announced an exciting expansion of its partnership with Arineta, a key player in cardiovascular imaging. This strategic collaboration now encompasses sales representation for Arineta's innovative SpotLight™ CT systems, aimed at transforming the cardiac imaging landscape in the U.S.
Deepening Existing Relationships
The relationship between Catalyst and Arineta has been growing through Catalyst's Propel Partner Program, which has enabled Catalyst to provide essential installation, repair, and maintenance services for Arineta's advanced cardiac CT systems over the past two years. This new phase positions Catalyst as more than just a service partner; it has become a vital component in Arineta's North American growth strategy, tasked with driving sales, supporting existing leads, and generating fresh opportunities.
Shared Vision for Progress
Martin Shirley, President and CEO of Catalyst MedTech, expressed his excitement for the enhanced partnership, stating, "At Catalyst, we don't just maintain technology—we accelerate it. This expanded relationship with Arineta exemplifies how our Propel Program can unlock untapped potential for OEMs." He emphasized that their expertise in sales, coupled with a solid understanding of the cardiology market, will help Arineta broaden their customer reach more effectively.
Commitment to Cardiovascular Innovation
Doug Ryan, CEO of Arineta, shared his enthusiasm regarding the partnership, saying, "Catalyst has been a trusted partner in supporting our installation, upgrades, and customer service programs. We are pleased to utilize them in an expanded capacity throughout the entire customer lifecycle." He noted that this collaboration positions Arineta to meet the surge in demand for cardiac CT imaging.
Expanding Access to Advanced Diagnostics
Arineta’s SpotLight™ and SpotLight™ Duo CT scanners are pioneering advancements in the field of cardiac imaging. These state-of-the-art systems are renowned for delivering high-quality imaging with the efficiency of single-heartbeat cardiac CT angiography. This strategic partnership allows Catalyst to enhance its foothold in the cardiovascular segment, leveraging its extensive relationships and technical expertise to provide unparalleled solutions in cardiac imaging.
Sales Organization Activation
In addition to supporting existing qualified leads, Catalyst's dedicated sales team will open up new sales channels, enhancing access to advanced cardiac CT imaging solutions across various medical settings. This effort aligns with Catalyst’s mission to drive growth not only for itself but also for healthcare providers that prioritize patient care.
A Model for Success
The collaboration serves as a testament to the Propel Partner Program's ability to facilitate rapid scaling for OEMs in the U.S. market. Catalyst MedTech understands that providing comprehensive sales momentum and access to the market is just as crucial as their service capabilities.
This Partnership as a Catalyst for Change
As stated by Martin Shirley, "We see ourselves as the catalyst for progress in diagnostic imaging—delivering value, access, and acceleration for our partners and their customers." This partnership reflects Catalyst's commitment to innovating and improving the practices of cardiovascular imaging.
Conclusion
Catalyst MedTech continues to pave new paths in the medical technology sector, demonstrating its proactive approach by enhancing its partnership with Arineta. Their combined efforts are sure to lead to groundbreaking advancements in cardiac imaging solutions, ultimately benefiting healthcare providers and patients alike.
Frequently Asked Questions
What is the nature of the partnership between Catalyst MedTech and Arineta?
The partnership focuses on expanding sales representation for Arineta's SpotLight™ CT systems, enhancing support for their North American growth strategy.
How long has Catalyst been involved with Arineta?
Catalyst has been working with Arineta for over two years, providing essential services for their cardiac CT systems.
What are Arineta's SpotLight™ technologies known for?
They are known for their innovative single-heartbeat cardiovascular and thoracic CT scanning capabilities.
What role does Catalyst’s sales organization play in this partnership?
Catalyst's sales team is responsible for pursuing new business opportunities and activating new sales channels for Arineta's technologies.
How does this partnership benefit healthcare providers?
It enhances their access to advanced cardiac imaging technologies, aimed at improving patient care and diagnostic capabilities.
